TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T01566 XX ID T01566 XX DT 19.09.1995 (created); ewi. DT 12.01.2010 (updated); jig. CO Copyright (C), QIAGEN. XX FA Max-isoform3 XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G003958 MAX; HGNC: Max. XX CL C0012; bHLH-ZIP. XX SZ 103 AA; 12.1 kDa (cDNA) (calc.), 16.5 kDa (SDS) XX SQ MSDNDDIEVESDEEQPRFQSAADKRAHHNALERKRRDHIKDSFHSLRDSVPSLQGEKASR SQ AQILDKATEYIQYMRRKNHTHQQDIDDLKRQNALLEQQGESES XX SC Swiss-Prot#P61244-3 XX FT 24 75 PF00010; Helix-loop-helix DNA-binding domain. FT 24 75 PS50888; HLH. FT 29 80 SM00353; finulus. XX SF C-terminal splice variant of Max; SF additionally both N-terminal splice variants have been found [1]; SF lacks NLS of Max and thus requires heterodimerization with c-Myc to translocate to the nucleus; SF Max-isoform3/Max heterodimers observed only in vitro, not found in vivo [1]; XX FF Max-isoform3 enhances the co-transforming activity of c-myc and ras [1]; XX IN T00140 c-Myc-isoform1; human, Homo sapiens. IN T01567 Max-isoform1; human, Homo sapiens. IN T00489 Max-isoform2; human, Homo sapiens. IN T01566 Max-isoform3; human, Homo sapiens. XX MX M01034 V$EBOX_Q6_01. MX M00119 V$MAX_01. MX M00118 V$MYCMAX_01. MX M00123 V$MYCMAX_02. MX M00615 V$MYCMAX_03. MX M00322 V$MYCMAX_B. MX M00799 V$MYC_Q2. XX DR TRANSPATH: MO000025771. DR EMBL: X60287; DR UniProtKB: P61244-3; XX RN [1]; RE0003350. RX PUBMED: 1566084. RA Maekelae T. P., Koskinen P. J., Vaestrik I., Alitalo K. RT Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation RL Science 256:373-377 (1992). XX //